ImmunoFusion is the largest database for researching fusion genes in cancer, integrating genomic data from over 10,000 pan-cancer patients with immune-oncology profiling across immunotherapy-treated and untreated cohorts.
The platform integrates comprehensive genomic data from over 10,000 pan-cancer patients encompassing projects such as The Cancer Genome Atlas (TCGA), Therapeutically Applicable Research to Generate Effective Treatments (TARGET), and Clinical Proteomic Tumor Analysis Consortium (CPTAC). Additionally, it includes data from more than 4,000 cancer samples from patients with 10 distinct cancer types who have been treated with Immune Checkpoint Inhibitors (ICIs).
2025-08-15: Release version v1.0.
2025-06-10: Database updated for confident fusions.
2025-06-05: First draft on bioRxiv.
Crafted with R Shiny, bslib, and shinyWidgets. We are committed to delivering a flawless user experience.
ImmunoFusion is for research purposes only. It does not use cookies or collect personal information. Clinical use is at your own risk.
IO = Immune Checkpoint Inhibitor treated cohorts. See the Cohort page for per-cohort details and the fusion landscape.
Explore fusion data distribution by Frequency, Localization, and Composition.
Active global filters (cohorts, fusion type, Score, tools, genes, fusions) restrict which fusions are included. Adjust filters to narrow or broaden the fusion set visualized in each distribution.
Multi-Dimensional
Compare tumor microenvironment (TME) estimates or IOBR immune signatures between Fusion+ and Fusion- samples within a single cohort.
Active global filters (fusion type, Score, tools, genes, fusions) define Fusion+ status: a sample is Fusion+ only if it carries at least one fusion passing ALL active filters. Adjust filters to refine grouping.
All results are computed on demand when you click Run.
Explore associations between gene fusions and molecular features, clinical response, or pairwise gene-gene relationships.
Active global filters (cohorts, fusion type, Score, tools, genes, fusions) define what constitutes a Fusion+ event --- a sample is Fusion+ only if it carries at least one fusion passing ALL active filters. Adjust filters to refine the Fusion+ vs Fusion- grouping.
All results are computed on demand when you click Run.
Assess the prognostic value of gene fusions using Kaplan-Meier survival analysis.
Active global filters (fusion type, Score, tools) define Fusion+ status: a sample is Fusion+ only if it carries at least one fusion passing ALL active filters. Adjust filters to refine the Fusion+ vs Fusion- grouping.
All results are computed on demand when you click Run.
Assess the prognostic value of gene fusions using Cox proportional hazards regression.
Active global filters (fusion type, Score, tools) define Fusion+ status for each gene: a sample is Fusion+ for a given gene only if the fusion passes ALL active filters. Adjust filters to refine the grouping.
All results are computed on demand when you click Run.
Explore the fusion landscape within a single cohort as an interactive OncoPrint. Each column represents a sample; each row represents a gene or gene pair. Colored rectangles within cells indicate specific fusion types detected.
Active global filters restrict which fusions are included.